Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs - PubMed (original) (raw)
Comparative Study
. 2006 Apr 15;59(8):713-20.
doi: 10.1016/j.biopsych.2005.10.018. Epub 2006 Feb 7.
Maurizio Popoli, Luca La Via, Stefania Moraschi, Ivan Vallini, Daniela Tardito, Ettore Tiraboschi, Laura Musazzi, Roberto Giambelli, Massimo Gennarelli, Giorgio Racagni, Sergio Barlati
Affiliations
- PMID: 16460696
- DOI: 10.1016/j.biopsych.2005.10.018
Comparative Study
Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs
Alessandro Barbon et al. Biol Psychiatry. 2006.
Abstract
Background: Several reports have shown that the glutamatergic system is involved in both the pathogenesis of affective and stress-related disorders and in the action of antidepressant drugs. In particular, antidepressant treatment was shown to modulate expression and function of ionotropic glutamate receptors, to inhibit glutamate release and to restore synaptic plasticity impaired by stress.
Methods: We analyzed the mRNA expression and RNA editing of alpha-amino-propionic-acid (AMPA) and kainate (KA) receptor subunits, in the pre-frontal/frontal cortex (P/FC) and hippocampus (HI) of rats chronically treated with three different drugs: the selective serotonin (5-HT) reuptake inhibitor fluoxetine, the selective noradrenaline (NA) reuptake inhibitor reboxetine and the tricyclic antidepressant desipramine.
Results: Our data showed that fluoxetine and desipramine exerted moderate but selective effects on glutamate receptor expression and editing, while reboxetine appeared to be the drug that affects glutamate receptors (GluR) most. The most consistent effect, observed with pronoradrenergic drugs (desipramine and reboxetine), was a decrease of GluR3 expression both in P/FC and HI. Interestingly, in HI, the same drugs also decreased the editing levels of either the flip (desipramine) or flop (reboxetine) form of GluR3.
Conclusions: Overall, these results point to specific and regionally discrete changes in the expression and editing level of glutamate receptors and, in particular, to a selective reduction of conductance for GluR3-containing receptors following treatment with antidepressant drugs. These data support the hypothesis that changes in glutamate neurotransmission are involved in the therapeutic effects induced by these drugs.
Similar articles
- Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex.
Barbon A, Fumagalli F, La Via L, Caracciolo L, Racagni G, Riva MA, Barlati S. Barbon A, et al. Exp Neurol. 2007 Nov;208(1):54-62. doi: 10.1016/j.expneurol.2007.07.009. Epub 2007 Jul 19. Exp Neurol. 2007. PMID: 17706642 - Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus.
Pittaluga A, Raiteri L, Longordo F, Luccini E, Barbiero VS, Racagni G, Popoli M, Raiteri M. Pittaluga A, et al. Neuropharmacology. 2007 Jul;53(1):27-36. doi: 10.1016/j.neuropharm.2007.04.006. Epub 2007 Apr 29. Neuropharmacology. 2007. PMID: 17543354 - Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels.
Barbon A, Caracciolo L, Orlandi C, Musazzi L, Mallei A, La Via L, Bonini D, Mora C, Tardito D, Gennarelli M, Racagni G, Popoli M, Barlati S. Barbon A, et al. Neurochem Int. 2011 Nov;59(6):896-905. doi: 10.1016/j.neuint.2011.07.013. Epub 2011 Aug 3. Neurochem Int. 2011. PMID: 21839792 - Glutamate receptor RNA editing in health and disease.
Barbon A, Barlati S. Barbon A, et al. Biochemistry (Mosc). 2011 Aug;76(8):882-9. doi: 10.1134/S0006297911080037. Biochemistry (Mosc). 2011. PMID: 22022961 Review. - A role for AMPA receptors in mood disorders.
Alt A, Nisenbaum ES, Bleakman D, Witkin JM. Alt A, et al. Biochem Pharmacol. 2006 Apr 28;71(9):1273-88. doi: 10.1016/j.bcp.2005.12.022. Epub 2006 Jan 24. Biochem Pharmacol. 2006. PMID: 16442080 Review.
Cited by
- Association of the GRIK4 rs1954787 polymorphism with clinical response in antidepressant-treated depressed patients: results from a prospective cohort and meta-analysis.
Chappell K, Colle R, El Asmar K, Gressier F, Bouligand J, Trabado S, Fève B, Becquemont L, Corruble E, Verstuyft C. Chappell K, et al. Mol Psychiatry. 2024 Oct 26. doi: 10.1038/s41380-024-02765-5. Online ahead of print. Mol Psychiatry. 2024. PMID: 39462036 - GluA2 AMPA glutamate receptor subunit exhibits codon 607 Q/R RNA editing in the lens.
Farooq M, Kaswala RH, Kleiman NJ, Kasinathan C, Frederikse PH. Farooq M, et al. Biochem Biophys Res Commun. 2012 Feb 10;418(2):273-7. doi: 10.1016/j.bbrc.2012.01.009. Epub 2012 Jan 10. Biochem Biophys Res Commun. 2012. PMID: 22266371 Free PMC article. - Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.
Yüksel C, Öngür D. Yüksel C, et al. Biol Psychiatry. 2010 Nov 1;68(9):785-94. doi: 10.1016/j.biopsych.2010.06.016. Epub 2010 Aug 21. Biol Psychiatry. 2010. PMID: 20728076 Free PMC article. Review. - Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants.
Musazzi L, Cattaneo A, Tardito D, Barbon A, Gennarelli M, Barlati S, Racagni G, Popoli M. Musazzi L, et al. BMC Neurosci. 2009 May 13;10:48. doi: 10.1186/1471-2202-10-48. BMC Neurosci. 2009. PMID: 19439074 Free PMC article. - Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.
Peng L, Gu L, Li B, Hertz L. Peng L, et al. Curr Neuropharmacol. 2014 Jul;12(4):365-79. doi: 10.2174/1570159X12666140828221720. Curr Neuropharmacol. 2014. PMID: 25342944 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous